Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ashton

Showing results (351-360 of 456) with videos related to

Pageof 46
Sort By:
Neuroscience and Biobehavioral Reviews|August 30, 2020
Prebiotics, probiotics, fermented foods and cognitive outcomes: A meta-analysis of randomized controlled trialsWolfgang Marx, Andrew Scholey, Joseph Firth, et al.
Cancers|July 2, 2020
Stratifying Brain Tumour Histological Sub-Types: The Application of ATR-FTIR Serum Spectroscopy in Secondary CareJames M Cameron, Christopher Rinaldi, Holly J Butler, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 29, 2019
Physical Activity as a Predictor of Clinical Trial Outcomes in Bipolar Depression: A Subanalysis of a Mitochondrial-Enhancing Nutraceutical Randomized Controlled TrialMelanie M Ashton, Mohammadreza Mohebbi, Alyna Turner, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|March 26, 2019
Protocol and Rationale: A 24-week Double-blind, Randomized, Placebo Controlled Trial of the Efficacy of Adjunctive <i>Garcinia mangostana</i>Linn. (Mangosteen) Pericarp for SchizophreniaAlyna Turner, John J McGrath, Olivia M Dean, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|December 23, 2020
Adjunctive <i>Garcinia mangostana</i> Linn. (Mangosteen) Pericarp for Schizophrenia: A 24-Week Double-blind, Randomized, Placebo Controlled Efficacy Trial: Péricarpe d'appoint Garcinia mangostana Linn (mangoustan) pour la schizophrénie : un essai d'efficacité de 24 semaines, à double insu, randomisé et contrôlé par placeboAlyna Turner, Andrea Baker, Olivia M Dean, et al.
Haematologica|March 11, 2017
Targeted therapy for a subset of acute myeloid leukemias that lack expression of aldehyde dehydrogenase 1A1Maura Gasparetto, Shanshan Pei, Mohammad Minhajuddin, et al.
Circulation Research|April 7, 2021
Prevention of Fibrosis and Pathological Cardiac Remodeling by SalinomycinRyan M Burke, Ronald A Dirkx, Pearl Quijada, et al.
Medical Care|June 8, 2000
Veterans Affairs Quality Enhancement Research Initiative in chronic heart failureC M Ashton, B Bozkurt, W B Colucci, et al.
Journal of Affective Disorders|November 16, 2020
Systematic review and meta-analysis of the role of personality disorder in randomised controlled trials of pharmacological interventions for adults with mood disordersBianca E Kavanagh, Melanie M Ashton, Stephanie P Cowdery, et al.
Peerj|April 13, 2016
Identification of Salmonella for public health surveillance using whole genome sequencingPhilip M Ashton, Satheesh Nair, Tansy M Peters, et al.
Pageof 46

Showing results (351-360 of 456) with videos related to

Sort By:
Pageof 46
Neuroscience and Biobehavioral Reviews|August 30, 2020
Prebiotics, probiotics, fermented foods and cognitive outcomes: A meta-analysis of randomized controlled trialsWolfgang Marx, Andrew Scholey, Joseph Firth, et al.
Cancers|July 2, 2020
Stratifying Brain Tumour Histological Sub-Types: The Application of ATR-FTIR Serum Spectroscopy in Secondary CareJames M Cameron, Christopher Rinaldi, Holly J Butler, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 29, 2019
Physical Activity as a Predictor of Clinical Trial Outcomes in Bipolar Depression: A Subanalysis of a Mitochondrial-Enhancing Nutraceutical Randomized Controlled TrialMelanie M Ashton, Mohammadreza Mohebbi, Alyna Turner, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|March 26, 2019
Protocol and Rationale: A 24-week Double-blind, Randomized, Placebo Controlled Trial of the Efficacy of Adjunctive <i>Garcinia mangostana</i>Linn. (Mangosteen) Pericarp for SchizophreniaAlyna Turner, John J McGrath, Olivia M Dean, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|December 23, 2020
Adjunctive <i>Garcinia mangostana</i> Linn. (Mangosteen) Pericarp for Schizophrenia: A 24-Week Double-blind, Randomized, Placebo Controlled Efficacy Trial: Péricarpe d'appoint Garcinia mangostana Linn (mangoustan) pour la schizophrénie : un essai d'efficacité de 24 semaines, à double insu, randomisé et contrôlé par placeboAlyna Turner, Andrea Baker, Olivia M Dean, et al.
Haematologica|March 11, 2017
Targeted therapy for a subset of acute myeloid leukemias that lack expression of aldehyde dehydrogenase 1A1Maura Gasparetto, Shanshan Pei, Mohammad Minhajuddin, et al.
Circulation Research|April 7, 2021
Prevention of Fibrosis and Pathological Cardiac Remodeling by SalinomycinRyan M Burke, Ronald A Dirkx, Pearl Quijada, et al.
Medical Care|June 8, 2000
Veterans Affairs Quality Enhancement Research Initiative in chronic heart failureC M Ashton, B Bozkurt, W B Colucci, et al.
Journal of Affective Disorders|November 16, 2020
Systematic review and meta-analysis of the role of personality disorder in randomised controlled trials of pharmacological interventions for adults with mood disordersBianca E Kavanagh, Melanie M Ashton, Stephanie P Cowdery, et al.
Peerj|April 13, 2016
Identification of Salmonella for public health surveillance using whole genome sequencingPhilip M Ashton, Satheesh Nair, Tansy M Peters, et al.
Pageof 46